title: Co-implanting orthotopic tissue creates stroma microenvironment enhancing growth and angiogenesis of multiple tumors.
abstract: Tumor models are needed to study cancer. Noninvasive imaging of tumors under native conditions in vivo is critical but challenging. Intravital microscopy (IVM) of subcutaneous tumors provides dynamic, continuous, long-term imaging at high resolution. Although popular, subcutaneous tumor models are often criticized for being ectopic and lacking orthotopic tissue microenvironments critical for proper development. Similar IVM of orthotopic and especially spontaneous tumors is seldom possible. Here, we generate and characterize tumor models in mice for breast, lung, prostate and ovarian cancer by co-engrafting tumor spheroids with orthotopic tissue in dorsal skin window chambers for IVM. We use tumor cells and tissue, both genetically engineered to express distinct fluorescent proteins, in order to distinguish neoplastic cells from engrafted tissue. IVM of this new, two-colored model reveals classic tumor morphology with red tumor cell nests surrounded by green stromal elements. The co-implanted tissue forms the supportive stroma and vasculature of these tumors. Tumor growth and angiogenesis are more robust when tumor cells are co-implanted with orthotopic tissue versus other tissues, or in the skin alone. The orthotopic tissue promotes tumor cell mitosis over apoptosis. With time, tumor cells can adapt to new environments and ultimately even grow better in the non-orthotopic tissue over the original orthotopic tissue. These models offer a significant advance by recreating an orthotopic microenvironment in an ectopic location that is still easy to image by IVM. These "ectopic-orthotopic" models provide an exceptional way to study tumor and stroma cells in cancer, and directly show the critical importance of microenvironment in the development of multiple tumors.
authors.affiliation: Sidney Kimmel Cancer Center, 10905 Road to the Cure, San Diego, CA, 92121, USA.
authors.forename: Per
authors.initials: P
authors.lastname: Borgstrom
authors.affiliation: Sidney Kimmel Cancer Center, 10905 Road to the Cure, San Diego, CA, 92121, USA ; Proteogenomics Research Institute for Systems Medicine, 11107 Roselle St, San Diego, CA, 92121, USA.
authors.forename: Phil
authors.initials: P
authors.lastname: Oh
authors.affiliation: Sidney Kimmel Cancer Center, 10905 Road to the Cure, San Diego, CA, 92121, USA ; Proteogenomics Research Institute for Systems Medicine, 11107 Roselle St, San Diego, CA, 92121, USA.
authors.forename: Malgorzata
authors.initials: M
authors.lastname: Czarny
authors.affiliation: Sidney Kimmel Cancer Center, 10905 Road to the Cure, San Diego, CA, 92121, USA.
authors.forename: Brian
authors.initials: B
authors.lastname: Racine
authors.affiliation: Sidney Kimmel Cancer Center, 10905 Road to the Cure, San Diego, CA, 92121, USA ; Proteogenomics Research Institute for Systems Medicine, 11107 Roselle St, San Diego, CA, 92121, USA.
authors.forename: Jan E
authors.initials: JE
authors.lastname: Schnitzer
references.citation: Clin Cancer Res. 2002 Jan;8(1):293-8
references.pmid: 11801572
references.citation: Genesis. 2000 Oct;28(2):75-81
references.pmid: 11064424
references.citation: Cancer Res. 2008 Nov 1;68(21):8643-53
references.pmid: 18974103
references.citation: Adv Drug Deliv Rev. 2005 Jan 2;57(1):135-52
references.pmid: 15518926
references.citation: Clin Cancer Res. 2005 Feb 1;11(3):971-81
references.pmid: 15709162
references.citation: Am J Pathol. 1993 Oct;143(4):1055-62
references.pmid: 7692730
references.citation: Microvasc Res. 2005 Jan;69(1-2):1-9
references.pmid: 15797254
references.citation: Cancer Metastasis Rev. 1998-1999;17(3):279-84
references.pmid: 10352881
references.citation: Nat Rev Cancer. 2008 Aug;8(8):579-91
references.pmid: 18596824
references.citation: Am J Pathol. 2007 Mar;170(3):793-804
references.pmid: 17322365
references.citation: Nat Rev Cancer. 2002 Apr;2(4):266-76
references.pmid: 12001988
references.citation: Cancer Res. 2007 Jan 15;67(2):511-9
references.pmid: 17234758
references.citation: Curr Biol. 1998 Mar 26;8(7):377-85
references.pmid: 9545195
references.citation: Breast Cancer Res. 2001;3(4):224-9
references.pmid: 11434873
references.citation: Clin Cancer Res. 2003 Nov 15;9(15):5532-9
references.pmid: 14654533
references.citation: Res Exp Med (Berl). 1980;177(2):125-34
references.pmid: 7003665
references.citation: Nat Biotechnol. 2007 Mar;25(3):327-37
references.pmid: 17334358
references.citation: Neoplasia. 2000 Jan-Apr;2(1-2):53-61
references.pmid: 10933068
references.citation: J Mammary Gland Biol Neoplasia. 1998 Apr;3(2):201-13
references.pmid: 10819528
references.citation: FEBS Lett. 1997 May 5;407(3):313-9
references.pmid: 9175875
references.citation: Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S134-9
references.pmid: 14508091
references.citation: Cancer Res. 1974 Aug;34(8):2109-13
references.pmid: 4842257
references.citation: Cancer Res. 2007 Jan 1;67(1):139-48
references.pmid: 17210693
references.citation: Cancer Res. 1981 May;41(5):1898-904
references.pmid: 7214358
references.citation: Cancer Treat Rep. 1983 Sep;67(9):753-65
references.pmid: 6883351